NO2010003I2 - Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav - Google Patents

Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav

Info

Publication number
NO2010003I2
NO2010003I2 NO2010003C NO2010003C NO2010003I2 NO 2010003 I2 NO2010003 I2 NO 2010003I2 NO 2010003 C NO2010003 C NO 2010003C NO 2010003 C NO2010003 C NO 2010003C NO 2010003 I2 NO2010003 I2 NO 2010003I2
Authority
NO
Norway
Prior art keywords
prukalopride
pharmaceutically acceptable
acid addition
addition salt
acceptable acid
Prior art date
Application number
NO2010003C
Other languages
English (en)
Other versions
NO2010003I1 (no
Original Assignee
Movetis Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8217407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2010003(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Movetis Nv filed Critical Movetis Nv
Publication of NO2010003I1 publication Critical patent/NO2010003I1/no
Publication of NO2010003I2 publication Critical patent/NO2010003I2/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO2010003C 1994-11-24 2010-03-05 Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav NO2010003I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203421 1994-11-24
PCT/EP1995/004519 WO1996016060A1 (en) 1994-11-24 1995-11-16 Enterokinetic benzamide

Publications (2)

Publication Number Publication Date
NO2010003I1 NO2010003I1 (no) 2010-03-05
NO2010003I2 true NO2010003I2 (no) 2012-08-27

Family

ID=8217407

Family Applications (3)

Application Number Title Priority Date Filing Date
NO19972143A NO312726B1 (no) 1994-11-24 1997-05-09 Enterokinetisk benzamid
NO2010003C NO2010003I2 (no) 1994-11-24 2010-03-05 Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
NO2019044C NO2019044I1 (no) 1994-11-24 2019-12-11 Dihydrobenzofurancarboksamid - forlenget SPC

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO19972143A NO312726B1 (no) 1994-11-24 1997-05-09 Enterokinetisk benzamid

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO2019044C NO2019044I1 (no) 1994-11-24 2019-12-11 Dihydrobenzofurancarboksamid - forlenget SPC

Country Status (40)

Country Link
US (3) US5854260A (no)
EP (1) EP0807110B1 (no)
JP (1) JP3046076B2 (no)
KR (1) KR100233489B1 (no)
CN (1) CN1071332C (no)
AP (1) AP777A (no)
AR (1) AR001769A1 (no)
AT (1) ATE217306T1 (no)
AU (1) AU704043B2 (no)
BG (1) BG63710B1 (no)
BR (1) BRPI9509819B8 (no)
CA (1) CA2205573C (no)
CY (2) CY2296B1 (no)
CZ (1) CZ292847B6 (no)
DE (2) DE122010000002I1 (no)
DK (1) DK0807110T3 (no)
EE (1) EE03313B1 (no)
ES (1) ES2177671T3 (no)
FI (1) FI120147B (no)
FR (1) FR10C0001I2 (no)
HR (1) HRP950571B1 (no)
HU (1) HU226560B1 (no)
IL (1) IL116101A (no)
LU (1) LU91644I2 (no)
MY (1) MY112944A (no)
NL (1) NL300435I1 (no)
NO (3) NO312726B1 (no)
NZ (1) NZ297753A (no)
OA (1) OA10422A (no)
PL (1) PL183713B1 (no)
PT (1) PT807110E (no)
RO (1) RO116279B1 (no)
RU (1) RU2154643C2 (no)
SI (1) SI0807110T1 (no)
SK (1) SK283499B6 (no)
TR (1) TR199501483A2 (no)
TW (1) TW490465B (no)
UA (1) UA59334C2 (no)
WO (1) WO1996016060A1 (no)
ZA (1) ZA959996B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
TW548103B (en) * 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
WO1999058527A2 (en) * 1998-05-14 1999-11-18 EGIS Gyógyszergyár Rt. Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
NZ511117A (en) * 1998-11-23 2002-11-26 Janssen Pharmaceutica Nv Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
TW592709B (en) * 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
CN1288730A (zh) * 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US20050085510A1 (en) * 2002-01-16 2005-04-21 Telefonaktiebolaget Lm Ericsson (Publ) Prucalopride-n-oxide
WO2011035142A1 (en) * 2009-09-18 2011-03-24 Adolor Corporation Use of opioid receptor antagonist for gastrointestinal tract disorders
GB201103397D0 (no) 2011-02-28 2011-04-13 Shire Movetis N V
CN102295594B (zh) * 2011-07-12 2016-01-20 上海医药工业研究院 4-n-取代-1-(3-甲氧基丙基)-4-哌啶胺类化合物及制备和应用
CA2845039A1 (en) 2011-08-18 2013-02-21 Shire Ag Combinations of a 5-ht4 receptor agonist and a pde4 inhibitor for use in therapy
EP3413891B1 (en) 2016-02-11 2024-01-03 Symed Labs Limited Processes for the preparation of highly pure prucalopride succinate
CN108727351B (zh) * 2017-04-19 2021-08-31 鲁南制药集团股份有限公司 一种普芦卡必利的精制方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CY2010001I2 (el) 2010-07-28
BRPI9509819B1 (pt) 2018-05-15
RO116279B1 (ro) 2000-12-29
SK65297A3 (en) 1997-10-08
BG101605A (en) 1998-02-27
NO972143D0 (no) 1997-05-09
NL300435I1 (nl) 2010-04-01
TR199501483A2 (tr) 1996-07-21
AP9700992A0 (en) 1997-07-31
ZA959996B (en) 1997-05-23
NO2010003I1 (no) 2010-03-05
PT807110E (pt) 2002-10-31
AU4299296A (en) 1996-06-17
FI120147B (fi) 2009-07-15
CY2010001I1 (el) 2010-07-28
NO972143L (no) 1997-05-09
DE69526679D1 (de) 2002-06-13
MX9703869A (es) 1997-09-30
MY112944A (en) 2001-10-31
CZ155597A3 (en) 1997-09-17
OA10422A (en) 2002-03-19
CA2205573C (en) 2006-05-09
EE03313B1 (et) 2000-12-15
JP3046076B2 (ja) 2000-05-29
KR100233489B1 (ko) 1999-12-01
SI0807110T1 (en) 2002-08-31
NZ297753A (en) 1998-05-27
BR9509819A (pt) 1997-09-30
DE69526679T2 (de) 2002-12-05
FI972203A (fi) 1997-05-23
HRP950571A2 (en) 1997-08-31
CA2205573A1 (en) 1996-05-30
EP0807110A1 (en) 1997-11-19
BRPI9509819B8 (pt) 2021-07-06
US5948794A (en) 1999-09-07
IL116101A (en) 1999-08-17
CN1071332C (zh) 2001-09-19
PL320297A1 (en) 1997-09-15
US6310077B1 (en) 2001-10-30
TW490465B (en) 2002-06-11
AR001769A1 (es) 1997-12-10
CY2296B1 (en) 2003-07-04
NO312726B1 (no) 2002-06-24
EP0807110B1 (en) 2002-05-08
SK283499B6 (sk) 2003-08-05
FR10C0001I1 (no) 2010-02-12
NO2019044I1 (no) 2019-12-11
CZ292847B6 (cs) 2003-12-17
FR10C0001I2 (fr) 2011-04-01
ES2177671T3 (es) 2002-12-16
HRP950571B1 (en) 2001-12-31
IL116101A0 (en) 1996-01-31
WO1996016060A1 (en) 1996-05-30
CN1164233A (zh) 1997-11-05
PL183713B1 (pl) 2002-07-31
ATE217306T1 (de) 2002-05-15
DK0807110T3 (da) 2002-09-02
AP777A (en) 1999-10-28
BG63710B1 (bg) 2002-10-31
LU91644I2 (en) 2010-03-29
RU2154643C2 (ru) 2000-08-20
JPH09512832A (ja) 1997-12-22
FI972203A0 (fi) 1997-05-23
HUT77375A (hu) 1998-04-28
HU226560B1 (en) 2009-04-28
US5854260A (en) 1998-12-29
AU704043B2 (en) 1999-04-15
DE122010000002I1 (de) 2011-12-01
UA59334C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
NO2018014I2 (no) Deferasirox eller et farmasøytisk akseptabelt salt derav
NO2010003I2 (no) Prukaloprid eller et farmasøytisk aksepterbart syreaddisjonssalt derav
NO2009004I2 (no) Mavacoxib eller et farmasøytisk akseptabelt salt derav
NO2009028I2 (no) Gefitinib eller et farmasøytisk akseptabelt salt derav
NO2009023I2 (no) Retapamulin eller farmasøytisk akseptabelt salt derav
NO2011007I1 (no) Ticagrelor eller et farmasøytisk akseptabelt salt derav
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DK0884319T3 (da) N-(1-nbutyl-4-piperidyl)methyl-3,4-dihydro-2H-1,3-oxazino-3,2a-indol-10-carboxamid eller et farmaceutisk acceptabelt salt deraf
NO2009007I2 (no) Robenakoksib, eller et farmasøytisk akseptabelt salt derav, eller en farmasøytisk akseptabel in vivo hydrolyserbar ester derav
NO2001002I1 (no) Lamivudin, eventuelt i form av et farmasøytisk godtgbart salt
DE69703385T2 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
DE69521474D1 (de) Aufeinanderfolgende Flügel-Entfernung
NO943888D0 (no) Farmasöytisk preparat
FI954007A (fi) Substituoitujen 4-fenyyli-6-amino-nikotiinihappojohdannaisten käyttö lääkeaineena
DE59402189D1 (de) 2-Keto-3-methyl-4-hydroxy-valeriansäure
NO950477D0 (no) Aminosyrederivater
DE69606053T2 (de) Modifizierte fluorsulfonsäure
ATE230734T1 (de) 3-alkoxyisoxazol-4-yl-substituierte 2- aminocarbonsäurederivate
EE9800186A (et) Tolfenaamhapet või selle farmatseutiliselt vastuvõetavat soola sisaldav kiiresti vabastav tablett
DE59402621D1 (de) Fluor-trifluormethylbenzoesäure-Derivate
DE69424753T2 (de) Elektrokardiograph
NO306159B1 (no) 5-arylisoksazol-4-substituerte 2-aminokarboksylsyreforbindelser
DE69616554D1 (de) Sialinsäure-derivate
NO950950D0 (no) Farmasöytisk preparat